410576006: Cycloplegic agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2466028016 Cycloplegic agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2472232016 Cycloplegic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

192001000077114 agent cycloplégique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
agent cycloplégique	Is a	agent ophtalmique	false	Inferred relationship	Some
agent cycloplégique	Is a	Muscarinic receptor antagonist	false	Inferred relationship	Some
agent cycloplégique	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Muscarinic receptor antagonist (disposition)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Atropine sulfate 10 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 10 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 1% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate hydrochloride 5 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate hydrochloride 1% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate hydrochloride 0.5% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 10 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 20 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 2% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Hyoscine hydrobromide 0.25% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Tropicamide 1% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Tropicamide 0.5% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing hydroxyamphetamine hydrobromide and tropicamide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 0.031% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 0.062% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 0.1% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 1.25 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 0.25% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 5 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 1% preservative-free eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 20 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate hydrochloride 1% preservative-free eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 0.125% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 0.25% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 0.5% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 1% preservative-free eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 2% preservative-free eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Hyoscine hydrobromide 0.125% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Hyoscine hydrobromide 0.5% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing atropine in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine sulfate 5 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing homatropine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing cyclopentolate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing tropicamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cycloplegic preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Hyoscine hydrobromide [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine methylbromide 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine methylbromide 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine hydrobromide 5% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate hydrochloride 2% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Tropicamide 5mg ophthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Antispasmodic homatropine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Ophthalmic hyoscine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Homatropine methylbromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate hydrochloride + phenylephrine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Product containing homatropine methylbromide and hydrocodone bitartrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent cycloplégique	Inferred relationship	Some
Atropine (substance)	Is a	False	agent cycloplégique	Inferred relationship	Some
Homatropine (substance)	Is a	False	agent cycloplégique	Inferred relationship	Some
Cyclopentolate (substance)	Is a	False	agent cycloplégique	Inferred relationship	Some
Scopolamine (substance)	Is a	False	agent cycloplégique	Inferred relationship	Some
Tropicamide (substance)	Is a	False	agent cycloplégique	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2466028016	Cycloplegic agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2472232016	Cycloplegic agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
192001000077114	agent cycloplégique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module